{"entity":{"type":"insider","cik":"0001503383","url":"/insider/0001503383","json_url":"/insider/0001503383.json","name":"REYNOLDS FRANCIS","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":460,"n_filings":142,"first":"2011-12-30","last":"2014-05-09","span_basis":"filed_date"},"name_variants":[{"name":"REYNOLDS FRANCIS","source":"filing","n_filings":142,"first_seen":"2011-12-30","last_seen":"2014-05-09"}],"transactions":[{"id":7064657,"accession":"0001181431-14-018898","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-018898","line_url":"/filing/0001181431-14-018898#line-3","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","total_whole":"15,000","shares_owned_after":9045920.0,"shares_owned_after_display":"9,045,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-09","filed_date":"2014-05-09","scope":"insider"},{"id":7064655,"accession":"0001181431-14-018898","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-018898","line_url":"/filing/0001181431-14-018898#line-2","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.19,"price_display":"1.19","price_state":"stated","total_value":14875.0,"total_display":"14,875.00","total_whole":"14,875","shares_owned_after":9058420.0,"shares_owned_after_display":"9,058,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-08","filed_date":"2014-05-09","scope":"insider"},{"id":7064653,"accession":"0001181431-14-018898","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-018898","line_url":"/filing/0001181431-14-018898#line-1","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":30000.0,"total_display":"30,000.00","total_whole":"30,000","shares_owned_after":9070920.0,"shares_owned_after_display":"9,070,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-07","filed_date":"2014-05-09","scope":"insider"},{"id":6553259,"accession":"0001181431-14-018012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-018012","line_url":"/filing/0001181431-14-018012#line-3","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21200.0,"shares_display":"21,200","price_per_share":1.79,"price_display":"1.79","price_state":"stated","total_value":37948.0,"total_display":"37,948.00","total_whole":"37,948","shares_owned_after":9083420.0,"shares_owned_after_display":"9,083,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-05","filed_date":"2014-05-06","scope":"insider"},{"id":6553252,"accession":"0001181431-14-018012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-018012","line_url":"/filing/0001181431-14-018012#line-2","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3800.0,"shares_display":"3,800","price_per_share":2.05,"price_display":"2.05","price_state":"stated","total_value":7790.0,"total_display":"7,790.00","total_whole":"7,790","shares_owned_after":9095920.0,"shares_owned_after_display":"9,095,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-02","filed_date":"2014-05-06","scope":"insider"},{"id":6553248,"accession":"0001181431-14-018012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-018012","line_url":"/filing/0001181431-14-018012#line-1","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.95,"price_display":"1.95","price_state":"stated","total_value":24375.0,"total_display":"24,375.00","total_whole":"24,375","shares_owned_after":9108420.0,"shares_owned_after_display":"9,108,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-01","filed_date":"2014-05-06","scope":"insider"},{"id":6641403,"accession":"0001181431-14-017417","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-017417","line_url":"/filing/0001181431-14-017417#line-3","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.89,"price_display":"1.89","price_state":"stated","total_value":23625.0,"total_display":"23,625.00","total_whole":"23,625","shares_owned_after":9120920.0,"shares_owned_after_display":"9,120,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-30","filed_date":"2014-05-01","scope":"insider"},{"id":6641400,"accession":"0001181431-14-017417","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-017417","line_url":"/filing/0001181431-14-017417#line-2","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.82,"price_display":"1.82","price_state":"stated","total_value":22750.0,"total_display":"22,750.00","total_whole":"22,750","shares_owned_after":9133420.0,"shares_owned_after_display":"9,133,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-29","filed_date":"2014-05-01","scope":"insider"},{"id":6641396,"accession":"0001181431-14-017417","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-017417","line_url":"/filing/0001181431-14-017417#line-1","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.76,"price_display":"1.76","price_state":"stated","total_value":22000.0,"total_display":"22,000.00","total_whole":"22,000","shares_owned_after":9145920.0,"shares_owned_after_display":"9,145,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-28","filed_date":"2014-05-01","scope":"insider"},{"id":6430292,"accession":"0001181431-14-016952","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-016952","line_url":"/filing/0001181431-14-016952#line-4","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.51,"price_display":"1.51","price_state":"stated","total_value":18875.0,"total_display":"18,875.00","total_whole":"18,875","shares_owned_after":9158420.0,"shares_owned_after_display":"9,158,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-25","filed_date":"2014-04-25","scope":"insider"},{"id":6430289,"accession":"0001181431-14-016952","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-016952","line_url":"/filing/0001181431-14-016952#line-3","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.51,"price_display":"1.51","price_state":"stated","total_value":18875.0,"total_display":"18,875.00","total_whole":"18,875","shares_owned_after":9170920.0,"shares_owned_after_display":"9,170,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-24","filed_date":"2014-04-25","scope":"insider"},{"id":6430286,"accession":"0001181431-14-016952","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-016952","line_url":"/filing/0001181431-14-016952#line-2","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":19000.0,"total_display":"19,000.00","total_whole":"19,000","shares_owned_after":9183420.0,"shares_owned_after_display":"9,183,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-23","filed_date":"2014-04-25","scope":"insider"},{"id":6430282,"accession":"0001181431-14-016952","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-016952","line_url":"/filing/0001181431-14-016952#line-1","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":19000.0,"total_display":"19,000.00","total_whole":"19,000","shares_owned_after":9195920.0,"shares_owned_after_display":"9,195,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-22","filed_date":"2014-04-25","scope":"insider"},{"id":6697423,"accession":"0001181431-14-016609","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-016609","line_url":"/filing/0001181431-14-016609#line-4","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.57,"price_display":"1.57","price_state":"stated","total_value":19625.0,"total_display":"19,625.00","total_whole":"19,625","shares_owned_after":9208420.0,"shares_owned_after_display":"9,208,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-21","filed_date":"2014-04-21","scope":"insider"},{"id":6697421,"accession":"0001181431-14-016609","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-016609","line_url":"/filing/0001181431-14-016609#line-3","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":19375.0,"total_display":"19,375.00","total_whole":"19,375","shares_owned_after":9220920.0,"shares_owned_after_display":"9,220,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-17","filed_date":"2014-04-21","scope":"insider"},{"id":6697419,"accession":"0001181431-14-016609","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-016609","line_url":"/filing/0001181431-14-016609#line-2","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.57,"price_display":"1.57","price_state":"stated","total_value":19625.0,"total_display":"19,625.00","total_whole":"19,625","shares_owned_after":9233420.0,"shares_owned_after_display":"9,233,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-16","filed_date":"2014-04-21","scope":"insider"},{"id":6697416,"accession":"0001181431-14-016609","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-016609","line_url":"/filing/0001181431-14-016609#line-1","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.57,"price_display":"1.57","price_state":"stated","total_value":19625.0,"total_display":"19,625.00","total_whole":"19,625","shares_owned_after":9245920.0,"shares_owned_after_display":"9,245,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-15","filed_date":"2014-04-21","scope":"insider"},{"id":7050560,"accession":"0001181431-14-016159","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-016159","line_url":"/filing/0001181431-14-016159#line-3","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.62,"price_display":"1.62","price_state":"stated","total_value":20250.0,"total_display":"20,250.00","total_whole":"20,250","shares_owned_after":9258420.0,"shares_owned_after_display":"9,258,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-14","filed_date":"2014-04-15","scope":"insider"},{"id":7050557,"accession":"0001181431-14-016159","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-016159","line_url":"/filing/0001181431-14-016159#line-2","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.63,"price_display":"1.63","price_state":"stated","total_value":20375.0,"total_display":"20,375.00","total_whole":"20,375","shares_owned_after":9270920.0,"shares_owned_after_display":"9,270,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-11","filed_date":"2014-04-15","scope":"insider"},{"id":7050555,"accession":"0001181431-14-016159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-016159","line_url":"/filing/0001181431-14-016159#line-1","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.64,"price_display":"1.64","price_state":"stated","total_value":20500.0,"total_display":"20,500.00","total_whole":"20,500","shares_owned_after":9283420.0,"shares_owned_after_display":"9,283,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-10","filed_date":"2014-04-15","scope":"insider"},{"id":6177116,"accession":"0001181431-14-015923","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-015923","line_url":"/filing/0001181431-14-015923#line-3","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":19375.0,"total_display":"19,375.00","total_whole":"19,375","shares_owned_after":9295920.0,"shares_owned_after_display":"9,295,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-09","filed_date":"2014-04-09","scope":"insider"},{"id":6177113,"accession":"0001181431-14-015923","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-015923","line_url":"/filing/0001181431-14-015923#line-2","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.62,"price_display":"1.62","price_state":"stated","total_value":20250.0,"total_display":"20,250.00","total_whole":"20,250","shares_owned_after":9308420.0,"shares_owned_after_display":"9,308,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-08","filed_date":"2014-04-09","scope":"insider"},{"id":6177111,"accession":"0001181431-14-015923","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-015923","line_url":"/filing/0001181431-14-015923#line-1","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.62,"price_display":"1.62","price_state":"stated","total_value":20250.0,"total_display":"20,250.00","total_whole":"20,250","shares_owned_after":9320920.0,"shares_owned_after_display":"9,320,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-07","filed_date":"2014-04-09","scope":"insider"},{"id":6489946,"accession":"0001181431-14-015785","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-015785","line_url":"/filing/0001181431-14-015785#line-2","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.7,"price_display":"1.70","price_state":"stated","total_value":21250.0,"total_display":"21,250.00","total_whole":"21,250","shares_owned_after":9333420.0,"shares_owned_after_display":"9,333,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-04","filed_date":"2014-04-07","scope":"insider"},{"id":6489944,"accession":"0001181431-14-015785","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-015785","line_url":"/filing/0001181431-14-015785#line-1","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":21500.0,"total_display":"21,500.00","total_whole":"21,500","shares_owned_after":9345920.0,"shares_owned_after_display":"9,345,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-03","filed_date":"2014-04-07","scope":"insider"},{"id":7031039,"accession":"0001181431-14-015419","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-015419","line_url":"/filing/0001181431-14-015419#line-3","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.68,"price_display":"1.68","price_state":"stated","total_value":21000.0,"total_display":"21,000.00","total_whole":"21,000","shares_owned_after":9358420.0,"shares_owned_after_display":"9,358,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-02","filed_date":"2014-04-03","scope":"insider"},{"id":7031038,"accession":"0001181431-14-015419","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-015419","line_url":"/filing/0001181431-14-015419#line-2","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.7,"price_display":"1.70","price_state":"stated","total_value":21250.0,"total_display":"21,250.00","total_whole":"21,250","shares_owned_after":9370920.0,"shares_owned_after_display":"9,370,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-01","filed_date":"2014-04-03","scope":"insider"},{"id":7031036,"accession":"0001181431-14-015419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-015419","line_url":"/filing/0001181431-14-015419#line-1","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.74,"price_display":"1.74","price_state":"stated","total_value":21750.0,"total_display":"21,750.00","total_whole":"21,750","shares_owned_after":9383420.0,"shares_owned_after_display":"9,383,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-31","filed_date":"2014-04-03","scope":"insider"},{"id":9253253,"accession":"0001181431-14-015401","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-015401","line_url":"/filing/0001181431-14-015401#line-2","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.76,"price_display":"1.76","price_state":"stated","total_value":22000.0,"total_display":"22,000.00","total_whole":"22,000","shares_owned_after":9398920.0,"shares_owned_after_display":"9,398,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-28","filed_date":"2014-04-03","scope":"insider"},{"id":9253252,"accession":"0001181431-14-015401","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-015401","line_url":"/filing/0001181431-14-015401#line-1","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":21875.0,"total_display":"21,875.00","total_whole":"21,875","shares_owned_after":9411420.0,"shares_owned_after_display":"9,411,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-27","filed_date":"2014-04-03","scope":"insider"},{"id":6253719,"accession":"0001181431-14-014031","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-014031","line_url":"/filing/0001181431-14-014031#line-3","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.71,"price_display":"1.71","price_state":"stated","total_value":21375.0,"total_display":"21,375.00","total_whole":"21,375","shares_owned_after":9423920.0,"shares_owned_after_display":"9,423,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-26","filed_date":"2014-03-26","scope":"insider"},{"id":6609581,"accession":"0001181431-14-014398","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-014398","line_url":"/filing/0001181431-14-014398#line-2","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.76,"price_display":"1.76","price_state":"stated","total_value":22000.0,"total_display":"22,000.00","total_whole":"22,000","shares_owned_after":9398920.0,"shares_owned_after_display":"9,398,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-25","filed_date":"2014-03-28","scope":"insider"},{"id":6253716,"accession":"0001181431-14-014031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-014031","line_url":"/filing/0001181431-14-014031#line-2","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.78,"price_display":"1.78","price_state":"stated","total_value":22250.0,"total_display":"22,250.00","total_whole":"22,250","shares_owned_after":9436420.0,"shares_owned_after_display":"9,436,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-25","filed_date":"2014-03-26","scope":"insider"},{"id":6609578,"accession":"0001181431-14-014398","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-014398","line_url":"/filing/0001181431-14-014398#line-1","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":21875.0,"total_display":"21,875.00","total_whole":"21,875","shares_owned_after":9411420.0,"shares_owned_after_display":"9,411,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-24","filed_date":"2014-03-28","scope":"insider"},{"id":6253714,"accession":"0001181431-14-014031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-014031","line_url":"/filing/0001181431-14-014031#line-1","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22900.0,"shares_display":"22,900","price_per_share":1.85,"price_display":"1.85","price_state":"stated","total_value":42365.0,"total_display":"42,365.00","total_whole":"42,365","shares_owned_after":9448920.0,"shares_owned_after_display":"9,448,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-24","filed_date":"2014-03-26","scope":"insider"},{"id":6552902,"accession":"0001181431-14-013708","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-013708","line_url":"/filing/0001181431-14-013708#line-4","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":1.95,"price_display":"1.95","price_state":"stated","total_value":4095.0,"total_display":"4,095.00","total_whole":"4,095","shares_owned_after":9621820.0,"shares_owned_after_display":"9,621,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-21","filed_date":"2014-03-21","scope":"insider"},{"id":6552898,"accession":"0001181431-14-013708","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-013708","line_url":"/filing/0001181431-14-013708#line-3","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":2.01,"price_display":"2.01","price_state":"stated","total_value":25125.0,"total_display":"25,125.00","total_whole":"25,125","shares_owned_after":9623920.0,"shares_owned_after_display":"9,623,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-20","filed_date":"2014-03-21","scope":"insider"},{"id":6552894,"accession":"0001181431-14-013708","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-013708","line_url":"/filing/0001181431-14-013708#line-2","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":2.19,"price_display":"2.19","price_state":"stated","total_value":27375.0,"total_display":"27,375.00","total_whole":"27,375","shares_owned_after":9636420.0,"shares_owned_after_display":"9,636,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-19","filed_date":"2014-03-21","scope":"insider"},{"id":6552891,"accession":"0001181431-14-013708","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-013708","line_url":"/filing/0001181431-14-013708#line-1","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":2.29,"price_display":"2.29","price_state":"stated","total_value":28625.0,"total_display":"28,625.00","total_whole":"28,625","shares_owned_after":9648920.0,"shares_owned_after_display":"9,648,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-18","filed_date":"2014-03-21","scope":"insider"},{"id":6176919,"accession":"0001181431-14-013028","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-013028","line_url":"/filing/0001181431-14-013028#line-3","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":2.48,"price_display":"2.48","price_state":"stated","total_value":31000.0,"total_display":"31,000.00","total_whole":"31,000","shares_owned_after":9661420.0,"shares_owned_after_display":"9,661,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-17","filed_date":"2014-03-17","scope":"insider"},{"id":6176917,"accession":"0001181431-14-013028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-013028","line_url":"/filing/0001181431-14-013028#line-2","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":2.47,"price_display":"2.47","price_state":"stated","total_value":30875.0,"total_display":"30,875.00","total_whole":"30,875","shares_owned_after":9673920.0,"shares_owned_after_display":"9,673,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-14","filed_date":"2014-03-17","scope":"insider"},{"id":6176913,"accession":"0001181431-14-013028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-013028","line_url":"/filing/0001181431-14-013028#line-1","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":2.37,"price_display":"2.37","price_state":"stated","total_value":29625.0,"total_display":"29,625.00","total_whole":"29,625","shares_owned_after":9686420.0,"shares_owned_after_display":"9,686,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-13","filed_date":"2014-03-17","scope":"insider"},{"id":6961421,"accession":"0001181431-14-012421","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-012421","line_url":"/filing/0001181431-14-012421#line-3","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":2.3,"price_display":"2.30","price_state":"stated","total_value":28750.0,"total_display":"28,750.00","total_whole":"28,750","shares_owned_after":9698920.0,"shares_owned_after_display":"9,698,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-12","filed_date":"2014-03-12","scope":"insider"},{"id":6961418,"accession":"0001181431-14-012421","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-012421","line_url":"/filing/0001181431-14-012421#line-2","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":2.31,"price_display":"2.31","price_state":"stated","total_value":28875.0,"total_display":"28,875.00","total_whole":"28,875","shares_owned_after":9711420.0,"shares_owned_after_display":"9,711,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-11","filed_date":"2014-03-12","scope":"insider"},{"id":6961413,"accession":"0001181431-14-012421","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-012421","line_url":"/filing/0001181431-14-012421#line-1","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":2.37,"price_display":"2.37","price_state":"stated","total_value":29625.0,"total_display":"29,625.00","total_whole":"29,625","shares_owned_after":9723920.0,"shares_owned_after_display":"9,723,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-10","filed_date":"2014-03-12","scope":"insider"},{"id":6335684,"accession":"0001181431-14-011763","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-011763","line_url":"/filing/0001181431-14-011763#line-2","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":2.43,"price_display":"2.43","price_state":"stated","total_value":30375.0,"total_display":"30,375.00","total_whole":"30,375","shares_owned_after":9736420.0,"shares_owned_after_display":"9,736,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-07","filed_date":"2014-03-10","scope":"insider"},{"id":6335681,"accession":"0001181431-14-011763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-011763","line_url":"/filing/0001181431-14-011763#line-1","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":2.45,"price_display":"2.45","price_state":"stated","total_value":30625.0,"total_display":"30,625.00","total_whole":"30,625","shares_owned_after":9748920.0,"shares_owned_after_display":"9,748,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-06","filed_date":"2014-03-10","scope":"insider"},{"id":6515862,"accession":"0001181431-14-011110","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-011110","line_url":"/filing/0001181431-14-011110#line-3","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":2.44,"price_display":"2.44","price_state":"stated","total_value":30500.0,"total_display":"30,500.00","total_whole":"30,500","shares_owned_after":9748920.0,"shares_owned_after_display":"9,748,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-05","filed_date":"2014-03-05","scope":"insider"},{"id":6515860,"accession":"0001181431-14-011110","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-011110","line_url":"/filing/0001181431-14-011110#line-2","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":2.52,"price_display":"2.52","price_state":"stated","total_value":31500.0,"total_display":"31,500.00","total_whole":"31,500","shares_owned_after":9761420.0,"shares_owned_after_display":"9,761,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-04","filed_date":"2014-03-05","scope":"insider"},{"id":6515857,"accession":"0001181431-14-011110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-011110","line_url":"/filing/0001181431-14-011110#line-1","is_derivative":false,"issuer_cik":"0001292519","issuer_name":"INVIVO THERAPEUTICS HOLDINGS CORP.","issuer_ticker":"NVIV","issuer_name_source":null,"issuer_url":"/issuer/0001292519","owner_cik":"0001503383","owner_name":"REYNOLDS FRANCIS","owner_display_name":"REYNOLDS FRANCIS","owner_url":"/insider/0001503383","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":2.52,"price_display":"2.52","price_state":"stated","total_value":31500.0,"total_display":"31,500.00","total_whole":"31,500","shares_owned_after":9773920.0,"shares_owned_after_display":"9,773,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-03","filed_date":"2014-03-05","scope":"insider"}],"collapsed":true,"next_cursor":"2014-03-03|6515857","ledger_fault":false,"count":{"value":460,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":459,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":460},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001292519","name":"INVIVO THERAPEUTICS HOLDINGS CORP.","url":"/issuer/0001292519","role":"Director, Officer (CEO, CFO), Ten percent owner","n_filings":142,"first_seen":"2011-12-30","last_seen":"2014-05-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001503383","retrieved_at":"2026-08-23T05:10:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}